PUBM
PubMatic, Inc. Technology Software - Application
/12
Innovation Score
Patent Activity
/3
No patents found in USPTO database (last 2026-05-04).
Cash Runway
/3
Operating cash flow positive — self-funding.
Cash on hand:
Cash on hand:
Revenue Trajectory
/3
Revenue:
YoY Growth: -6.4%
YoY Growth: -6.4%
Management Quality
/3
Insider ownership: 6.9%
SBC/Revenue: 33.8%
No reverse splits detected
SBC/Revenue: 33.8%
No reverse splits detected
Key Metrics
Market Cap
Revenue
Revenue Growth (YoY)
-6.4%
Cash on Hand
Cash Runway
Cash Flow Positive
Shares Outstanding
38.4M
Insider Ownership
6.9%
SBC / Revenue
33.8%
Sector / Industry
Technology / Software - Application
7-Step Risk Assessment
How PUBM maps to our micro cap methodology:
- Innovation Signal No patents found. Innovation may be trade-secret-based or too early for filings.
- Cash Runway Check Cash flow positive. No dilution risk from capital raises.
- Revenue Trajectory -6.4% YoY growth on revenue. Revenue declining — investigate whether this is temporary or structural.
- Management Alignment Insiders hold 6.9% of shares. SBC is 33.8% of revenue.
- Competitive Moat Review the company's 10-K for barriers to entry: patents, network effects, switching costs, regulatory approvals. This step requires manual research.
- Catalyst Identification Look for upcoming catalysts: FDA decisions, contract wins, product launches, partnerships. Check recent 8-K filings and earnings transcripts.
- Position Sizing Micro caps carry outsized risk. Consider position sizing relative to conviction level and portfolio concentration. This is a company.
Financial Detail
Free Cash Flow
$50.8M
FCF Yield
10.5%
Return on Equity
-5.4%
Debt / Equity
16.8%
Gross Margin
63.6%
Profit Margin
-5.1%
Operating Margin
11.8%
Price / Book
1.83
Current Ratio
1.39
Dividend Yield
None
Share Count Change (YoY)
-2.5%
Share Count Change (3yr)
-11.0%
Quality Flags
Low Debt
FCF Positive
Share Cannibal
Buying Back
Free Cash Flow Trend
Growing
3yr CAGR: +6.4%
Consecutive Years FCF Positive
4
Annual FCF ($M):
2022: $38.3M
2023: $52.8M
2024: $34.9M
2025: $46.2M
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%)
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Disclaimer: This is an automated screening tool, not investment advice. Micro cap stocks are inherently risky with low liquidity and high volatility. The innovation score is based on publicly available data and may not reflect the full picture. Steps 5-7 of the methodology require your own research. See our full disclaimer.
Last screened: